IO Biotech Inc Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| NOVO HOLDINGS A/S | 02/17/2026 | 2.51 M | $1.53 M | 0.00% | 3.75% |
| IKARIAN CAPITAL, LLC | 02/18/2026 | 1.39 M | $844.28 K | -9.13% | 2.07% |
| BANK OF AMERICA CORP /DE/ | 02/17/2026 | 799.95 K | $486.37 K | 0.00% | 1.20% |
| MORGAN STANLEY | 02/13/2026 | 539.18 K | $328.31 K | -19.33% | 0.81% |
| BEACON POINTE ADVISORS, LLC | 02/18/2026 | 506.00 K | $308.10 K | 100.00% | 0.76% |
| BOOTHBAY FUND MANAGEMENT, LLC | 02/17/2026 | 451.85 K | $275.13 K | -23.57% | 0.68% |
| DAUNTLESS INVESTMENT GROUP, LLC | 02/17/2026 | 451.64 K | $275.00 K | 100.00% | 0.67% |
| MARSHALL WACE, LLP | 02/13/2026 | 429.34 K | $261.90 K | -59.21% | 0.64% |
| RENAISSANCE TECHNOLOGIES LLC | 02/12/2026 | 207.60 K | $126.41 K | -62.07% | 0.31% |
| MILLENNIUM MANAGEMENT LLC | 02/17/2026 | 138.72 K | $84.46 K | -90.04% | 0.21% |
| CITIGROUP INC | 02/13/2026 | 111.45 K | $67.86 K | 8,525.93% | 0.17% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 02/17/2026 | 75.00 K | $45.67 K | 0.00% | 0.11% |
| TWO SIGMA SECURITIES, LLC | 02/17/2026 | 44.76 K | $27.25 K | 100.00% | 0.07% |
| UBS GROUP AG | 01/29/2026 | 43.58 K | $26.54 K | 521.39% | 0.07% |
| GEODE CAPITAL MANAGEMENT, LLC | 02/09/2026 | 33.31 K | $20.28 K | 0.00% | 0.05% |
| HILTON CAPITAL MANAGEMENT, LLC | 02/12/2026 | 25.51 K | $15.53 K | 0.00% | 0.04% |
| ADAR1 CAPITAL MANAGEMENT, LLC | 02/18/2026 | 24.96 K | $15.20 K | 100.00% | 0.04% |
| PKS ADVISORY SERVICES, LLC | 02/02/2026 | 20.00 K | $12.18 K | 2.56% | 0.03% |
| VIRTU FINANCIAL LLC | 02/23/2026 | 19.08 K | $12.00 K | -51.16% | 0.03% |
| XTX TOPCO LTD | 02/17/2026 | 15.86 K | $9.66 K | -91.15% | 0.02% |
| SCIENTECH RESEARCH LLC | 02/17/2026 | 11.26 K | $6.85 K | 100.00% | 0.02% |
| SBI SECURITIES CO., LTD. | 02/03/2026 | 122 | $74 | 0.00% | 0.00% |
| GOLDMAN SACHS GROUP INC | 03/25/2026 | 0 | $0 | -100.00% | 0.00% |
| POINT72 ASSET MANAGEMENT, L.P. | 02/17/2026 | 0 | $0 | -100.00% | 0.00% |
| NEWEDGE ADVISORS, LLC | 02/18/2026 | 0 | $0 | -100.00% | 0.00% |
| QUADRATURE CAPITAL LTD | 02/17/2026 | 0 | $0 | -100.00% | 0.00% |
IO Biotech Inc institutional Ownership - FAQ's
During the previous two years, 29 institutional investors and hedge funds held shares of IO Biotech Inc. The most heavily invested institutionals were:
GSA CAPITAL PARTNERS LLP: 348,352
CITIGROUP INC: 72,495
JANE STREET GROUP, LLC: 57,974
UBS Group AG: 30,980
SBI Securities Co., Ltd.: 0
Novo Holdings A/S: 2.51 M
11.72% of IO Biotech Inc stock is owned by institutional investors.
Institutional investors have bought a total of 8.20 M shares in the last 24 months. This purchase volume represents approximately $2.30 M in transactions.